Lab study links epigenetic 'memory' of chronic inflammation to bowel cancer development

A laboratory study reported by Cancer Research UK finds that cells can retain an epigenetic imprint of past exposure to chronic inflammation — a form of cellular 'memory' that may represent a mechanistic link between conditions such as ulcerative colitis and the elevated risk of bowel cancer observed in affected individuals.

The research, described in Cancer Research UK's news coverage, shows that repeated or sustained inflammatory signalling leads to durable changes in chromatin organisation or DNA methylation patterns in intestinal cells. These persistent epigenetic alterations may prime cells towards dysregulated growth even after the acute inflammatory episode resolves, potentially contributing to neoplastic transformation over time.

The Cancer Research UK article is explicit that this is a laboratory study and that the relevance to human disease has not yet been established; the team notes that if the findings translate to human tissue they could inform strategies for cancer prevention in high-risk inflammatory bowel disease populations. No primary publication details — including journal, lead authors, or institution — are provided in the feed entry; readers interested in the primary data should seek the source paper via the Cancer Research UK article.

This finding is of interest to researchers in cancer epigenetics and gastrointestinal oncology, and to oncologists following the mechanistic basis of inflammation-associated cancer risk.